This is a Validated Antibody Database (VAD) review about human HEY2, based on 5 published articles (read how Labome selects the articles), using HEY2 antibody in all methods. It is aimed to help Labome visitors find the most suited HEY2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
HEY2 synonym: CHF1; GRIDLOCK; GRL; HERP1; HESR2; HRT2; bHLHb32; hairy/enhancer-of-split related with YRPW motif protein 2; HES-related repressor protein 1; HES-related repressor protein 2; HESR-2; HRT-2; cardiovascular basic helix-loop-helix factor 1; cardiovascular helix-loop-helix factor 1; class B basic helix-loop-helix protein 32; hCHF1; hHRT2; hairy and enhancer of split-related protein 2; hairy-related transcription factor 2; hairy/enhancer-of-split related with YRPW motif 2; protein gridlock homolog
Abcam
mouse polyclonal |
| In order to demonstrate that iPS-derived cardiomyocytes with a heterozygous GATA4-G296S missense mutation show impaired contractility, calcium handling, and metabolic activity, Abcam HEY2 antibody (Abcam, ab167280) was used in western blot on human samples (fig s5l). Cell (2016) ncbi |
mouse polyclonal |
| Abcam HEY2 antibody (Abcam, ab167280) was used in western blot on human samples (fig 2). Cytotherapy (2015) ncbi |
rabbit polyclonal |
| Abcam HEY2 antibody (Abcam, ab25404) was used in western blot on human samples . Int J Clin Exp Pathol (2014) ncbi |
rabbit polyclonal |
| Abcam HEY2 antibody (Abcam, ab25404) was used in western blot on mouse samples . PLoS ONE (2014) ncbi |
Proteintech Group
rabbit polyclonal |
| Proteintech Group HEY2 antibody (ProteinTech, 10597-1-AP) was used in immunohistochemistry - frozen section on mouse samples . Genesis (2014) ncbi |
Articles Reviewed
- Hu G, Liu H, Lai P, Guo Z, Xu L, Yao X, et al. Delta-like ligand 4 (Dll4) predicts the prognosis of clear cell renal cell carcinoma, and anti-Dll4 suppresses tumor growth in vivo. Int J Clin Exp Pathol. 2014;7:2143-52 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments